2018
DOI: 10.1053/j.jfas.2017.10.024
|View full text |Cite
|
Sign up to set email alerts
|

Malignant Hidradenocarcinoma in the Lower Extremity: A Case Report of a Rare Tumor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
6
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 17 publications
0
6
0
Order By: Relevance
“…In past reports, lesions mostly occurred in the head and neck region. Our case is only the second malignant transformation of NH to be reported in the lower leg [ 8 ]. Contrary to its benign counterpart, MNH shows aggressive behavior with a high frequency of local recurrence and metastasis.…”
Section: Discussionmentioning
confidence: 98%
“…In past reports, lesions mostly occurred in the head and neck region. Our case is only the second malignant transformation of NH to be reported in the lower leg [ 8 ]. Contrary to its benign counterpart, MNH shows aggressive behavior with a high frequency of local recurrence and metastasis.…”
Section: Discussionmentioning
confidence: 98%
“…It can recur locally or metastasize distantly. Only a few cases have been reported, and the differentiation from benign hidradenoma by only imaging is difficult ( 2 8 9 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, approximately 66% of patients present distant extension of the tumor (39% to lymph nodes and 28% to other distant organs that include bone, lung, pleura, skin, and among others), and the local recurrence rate of this type of tumor is high (up to 50%). Therefore, surgical treatment of the tumor is currently combined with regional lymphadenectomy whenever possible if there is regional lymph node involvement, and even prophylactically [ 2 , 3 , 4 , 8 , 9 , 10 ].…”
Section: Discussionmentioning
confidence: 99%
“…Sentinel node biopsy can be useful in the early diagnosis of lymph node metastases in the subclinical phase in those cases with lesions with data suggesting a high risk of malignancy, such as invasion more than 2 mm in depth, perineural invasion, and histological dedifferentiation [ 2 , 8 , 9 ].…”
Section: Discussionmentioning
confidence: 99%